Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transcranial Magnetic Stimulation in Misophonia
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
The purpose of the project is to assess the efficacy of parietal transcranial magnetic stimulation in misophonia. N=60 participants will undergo two transcranial magnetic stimulation sessions: one inhibitory and another excitatory. During both sessions, the parietal region will be stimulated. Participants will perform computerized tasks immediately before and after the stimulation, while EEG, heart rate, and skin temperature will be recorded. These recordings will be used to assess if TMS can be used to improve tolerance to misophonia triggers.
Official title: A Transcranial Magnetic Stimulation Approach to Treat Misophonia
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-09-02
Completion Date
2026-06-30
Last Updated
2025-09-09
Healthy Volunteers
No
Conditions
Interventions
Transcranial Magnetic Stimulation (TMS)
Transcranial Magnetic Stimulation (TMS) is an FDA-approved non-invasive brain stimulation technology. It is currently used for treating depression. Applications to other disorders such as OCD and anxiety using TMS are currently under investigation. TMS will be administered for 25 minutes.
Locations (1)
Mount Sinai West
New York, New York, United States